Transgenic plant as bioreactor has been used to produce recombinant proteins for medicinal purposes, including mammalian antibodies, blood substitutes and vaccines. As the demand for biopharmaceuticals is expected to increase, transgenic plants have the potential to provide virtually unlimited quantities of proteins for use as tools in both human health care and the bioscience. This paper reviews the recent developments in this field and the prospect of commercial applications.